Original Articles

Comparison of the Efficacy of Shorter Duration Maintenance Dose of 12 hours versus 24-hour Maintenance Dose of Intravenous MgSO4 for Management of Severe Pre-eclamptic Patients

  1. Consultant Gynecologist, Niazi hospital Johar town Lahore, Omar medical complex Johar Town (visiting consultant)
  2. Assistant professor, Obstetrics and Gynaecology, Chaudhary Muhammad Akram teaching and research hospital Lahore
  3. Consultant Gynecologist, Niazi hospital johar town Lahore, Omar medical complex Johar Town
  4. Senior registrar at CMA (Chaudhary Muhammad Akram teaching and research center)

Abstract

Objective: To compare the effectiveness and safety of 12-hour versus 24-hour
intravenous magnesium sulfate maintenance therapy in preventing seizures among
patients with severe pre-eclampsia.
Methods: A randomized controlled trial was conducted at the Obstetrics and
Gynaecology Department of Lahore General Hospital over 12 months. A total of 256
pregnant women with severe pre-eclampsia were randomized into two equal groups
receiving either 12-hour or 24-hour intravenous magnesium sulfate therapy. Patients were
monitored for seizures, vital signs, urine output, and adverse effects. Data were collected using a structured proforma and analyzed for efficacy and safety outcomes.
Results: Overall 256 patients randomized equally to 12-hour or 24-hour IV magnesium
sulfate maintenance therapy, both regimens showed comparable seizure control, with mean seizure counts of 0.11 ± 0.56 vs. 0.06 ± 0.41 (t = 0.759, df = 254, p = 0.448) and prophylaxis success rates of 96.1% vs. 97.7%. Adverse effects including poor
reflexes, flushing, drowsiness, hypothermia, and oliguria were statistically insignificant
across the groups (p > 0.05). Overall, the 12-hour and 24-hour magnesium sulfate
regimens demonstrated equivalent safety and efficacy (p > 0.05).
Conclusion: Both the 12-hour and 24-hour intravenous magnesium sulfate regimens
were found to be equally effective in preventing eclamptic seizures among women with
severe pre-eclampsia.

Metrics

259Abstract views
0Downloads

License

Copyright (c) 2026 Madiha Mushtaq, Iffat hamid, Iqra Khalid, Naveeda, Faiza Khan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/.) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More in this Issue